ADVFN - Advanced Financial Network.
HOME» NASDAQ » R » RSCR Stock Price » RSCR Stock News

Res-care Share News

 Res-care (mm) Stock Price
RSCR Stock Price
 Res-care (mm) Stock Chart
RSCR Stock Chart
 Res-care (mm) Stock News
RSCR Stock News
 Res-care (mm) Company Information
RSCR Company Information
 Res-care (mm) Stock Trades
RSCR Stock Trades

ResCare Gets $365.4 Million Buyout Offer From Canada's Onex

DOW JONES NEWSWIRES ResCare Inc. (RSCR) said Monday it received a proposal from Toronto-based investment firm Onex Corp. (ONEXF, OCX.T) to buy the stake of company it doesn't already own, valuing the provider of home care to the elderly and people with disabilities at $365.4 million. The $12.60 a share, made Saturday, is a 24% premium to Friday's closing price. The stock has declined 31% in the past year. Affiliates of Onex currently hold common and preferred stock that represents a 24.9% voting stake in the company. ResCare said its board has formed a committee of independent directors to evaluate the offer. In its proposal letter, Onex notes an agreement would give ResCare a 30-day period to solicit alternative offers, with a termination fee equal to 3% of the company's equity valued at the higher offer price. Onex has been making small acquisitions of late, in March announcing that it had bought Sport Supply Inc. (RBI) for about $172 million. Earlier this month, ResCare said its profit rose 14% even as revenue declined 2.3%, with President and Chief Executive Ralph G. Gronefeld Jr. calling the company's performance "solid despite the extremely difficult economic environment." -By Nathan Becker, Dow Jones Newswires; 212-416-2855;

Stock News for Res-care (RSCR)
No Recent News Available

Res-care and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations